WallStreetZenWallStreetZen

NASDAQ: KRRO
Korro Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for KRRO

Based on 4 analysts offering 12 month price targets for Korro Bio Inc.
Min Forecast
$90.00+43.02%
Avg Forecast
$126.25+100.62%
Max Forecast
$180.00+186.03%

Should I buy or sell KRRO stock?

Based on 4 analysts offering ratings for Korro Bio Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KRRO stock forecasts and price targets.

KRRO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-26

1 of 1

Forecast return on equity

Is KRRO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.83%

Forecast return on assets

Is KRRO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KRRO revenue forecast

What is KRRO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.0M
Avg 2 year Forecast
$37.0M
Avg 3 year Forecast
$107.0M

KRRO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRRO$62.93$126.25+100.62%Strong Buy
EXAI$4.03$8.00+98.51%Hold
ANL$13.75N/AN/A
STTK$10.59$20.00+88.86%Buy
ALEC$5.25$19.25+266.67%Strong Buy

Korro Bio Stock Forecast FAQ

Is Korro Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: KRRO) stock is to Strong Buy KRRO stock.

Out of 4 analysts, 1 (25%) are recommending KRRO as a Strong Buy, 3 (75%) are recommending KRRO as a Buy, 0 (0%) are recommending KRRO as a Hold, 0 (0%) are recommending KRRO as a Sell, and 0 (0%) are recommending KRRO as a Strong Sell.

If you're new to stock investing, here's how to buy Korro Bio stock.

What is KRRO's revenue growth forecast for 2027-2029?

(NASDAQ: KRRO) Korro Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.94%.

Korro Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast KRRO's revenue for 2027 to be $32,087,784, with the lowest KRRO revenue forecast at $32,087,784, and the highest KRRO revenue forecast at $32,087,784. On average, 1 Wall Street analysts forecast KRRO's revenue for 2028 to be $296,812,002, with the lowest KRRO revenue forecast at $296,812,002, and the highest KRRO revenue forecast at $296,812,002.

In 2029, KRRO is forecast to generate $858,348,222 in revenue, with the lowest revenue forecast at $858,348,222 and the highest revenue forecast at $858,348,222.

What is KRRO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KRRO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KRRO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year KRRO price target, the average KRRO price target is $126.25, with the highest KRRO stock price forecast at $180.00 and the lowest KRRO stock price forecast at $90.00.

On average, Wall Street analysts predict that Korro Bio's share price could reach $126.25 by Mar 28, 2025. The average Korro Bio stock price prediction forecasts a potential upside of 100.62% from the current KRRO share price of $62.93.

What is KRRO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KRRO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.